Disease management
Also, SELVAS Healthcare will be bringing to South Korea a foreign contender to the booming AI-based medical imaging market.
Also, researchers from Singapore and Kazakhstan have used AI and heat imaging for the early detection of breast cancer.
Also, Seegene will be leveraging Microsoft's AI to advance the development of syndromic quantitative PCR diagnostic tests globally.
This comes three months after getting regulatory approval from Singapore’s Health Sciences Authority for its latest digital twin solution.
The diabetes-focused company provides endocrinologists with tools to implement value-based care, collect data, and improve revenue growth and patient engagement.
CancerIQ provides personalized care plans to help providers detect cancer early and prevent progression of the disease, says Feyi Ayodele, founder and CEO of CancerIQ.
Also, mental health platform Amaha, formerly InnerHour, has received $6 million in additional Series A funding for its expansion.
The company's diagnostics platform helps predict how patients will respond to immunotherapy.
The company will use the funds to expand its commercial efforts and seek additional clinical validation of its tech-enabled offering.
More hospitals are coming into the fold in the coming months.